Tenofovir Disoproxil Fumarate Tablet, Coated
Product Images NDC 71921-105

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tenofovir Disoproxil Fumarate (NDC 71921-105). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Florida Pharmaceutical Products, Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

300mg (300mg)

300mg (300mg)
Label for Tenofovir Disoproxil Fumarate Tablets 300 mg, coated oral tablets, in a bottle of 30 tablets. The product is labeled by Florida Pharmaceutical Products, LLC, with NDC 71921-105. The label includes storage instructions, manufacturing details by Qilu Pharmaceutical Co., Ltd., and contact information.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Tenofovir Disoproxil Fumarate, depicting the molecular arrangement of its components including the purine base, phosphonate group, and fumarate moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.